Financial News

Biotech Skin Health Brand OneSkin Closes Series A Investment Round

Unilever Ventures is among investors in this San Francisco-based maker of topical skin longevity treatments.

OneSkin founders

San Francisco-based skin care brand OneSkin has closed its Series A investment round, bringing total funding for the brand to $20 million. Founded by four Brazilian PhD scientists in 2016, OneSkin offers topical skin longevity treatments. The company says its patented peptide and core ingredient, OS-01, reverses skin’s biological age by preventing the accumulation of senescent cells, a major driver of aging. The oversubscribed round was led by Selva Ventures, alongside with PLUS Capital, U...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters